ATE175358T1 - Behandlung des prämenstruellen oder späten lutealsphase-syndroms - Google Patents
Behandlung des prämenstruellen oder späten lutealsphase-syndromsInfo
- Publication number
- ATE175358T1 ATE175358T1 AT88910336T AT88910336T ATE175358T1 AT E175358 T1 ATE175358 T1 AT E175358T1 AT 88910336 T AT88910336 T AT 88910336T AT 88910336 T AT88910336 T AT 88910336T AT E175358 T1 ATE175358 T1 AT E175358T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- premenstrual
- luteal phase
- phase syndrome
- late luteal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, ***e
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Inorganic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyrane Compounds (AREA)
- Conversion Of X-Rays Into Visible Images (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11177187A | 1987-10-22 | 1987-10-22 | |
US07/244,944 US4971998A (en) | 1987-10-22 | 1988-09-15 | Methods for treating the premenstrual or late luteal phase syndrome |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE175358T1 true ATE175358T1 (de) | 1999-01-15 |
Family
ID=26809210
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT88910336T ATE175358T1 (de) | 1987-10-22 | 1988-10-21 | Behandlung des prämenstruellen oder späten lutealsphase-syndroms |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0386117B1 (de) |
JP (1) | JP2938463B2 (de) |
AT (1) | ATE175358T1 (de) |
DE (1) | DE3856295T2 (de) |
WO (1) | WO1989003692A1 (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5011688A (en) * | 1989-02-02 | 1991-04-30 | Calam Henry D | Liquid composition for the relief of premenstrual and menstrual discomforts |
US4962128A (en) * | 1989-11-02 | 1990-10-09 | Pfizer Inc. | Method of treating anxiety-related disorders using sertraline |
CA2039103A1 (en) * | 1990-03-29 | 1991-09-30 | David Wayne Robertson | Improvements in and relating to the selective occupation of serotonin 1c receptors |
US5589511A (en) * | 1990-08-13 | 1996-12-31 | Sepracor Inc. | Method for treating migraine headaches using optically pure S(+) fluoxetine |
US5708035A (en) * | 1991-02-04 | 1998-01-13 | Sepracor Inc. | Methods of use and compositions of R(-) fluoxetine |
US5455254A (en) * | 1991-02-15 | 1995-10-03 | Mondadori; Cesare | Substituted benzofuranylpiperidine as a nootropic agent |
ES2087497T3 (es) * | 1991-02-15 | 1996-07-16 | Ciba Geigy Ag | Benzofuranilpiperidina substituida como nootropico. |
FR2685204B1 (fr) * | 1991-12-19 | 1995-06-16 | Palmer Research | Compositions pharmaceutiques pour l'administration transcutanee de la fenfluramine. |
DE69429895T2 (de) * | 1993-06-28 | 2002-08-29 | American Home Products Corp., Madison | Neue Behandlungsmethoden durch Verwendung von Phenethylderivaten |
ATE199829T1 (de) * | 1994-06-03 | 2001-04-15 | Thejmde Trust | Meta substituierte arylalkylamine und therapeutische und diagnostische verwendung davon |
NZ508310A (en) * | 1998-04-24 | 2005-03-24 | Scarista Ltd | Pharmaceutical composition containing folate precursor and a serotonin uptake inhibitor or a noradrenaline reuptake inhibitor useful for treating depression |
US7034059B2 (en) | 2001-07-02 | 2006-04-25 | Sepracor Inc. | Methods of using norfluoxetine |
EP2305229A1 (de) * | 2001-12-05 | 2011-04-06 | Teva Women's Health, Inc. | Orale Verhütungsmittel zum Verhindern einer Schwangerschaft und Reduzierung von prämenstruellen Symptomen |
US20070111975A1 (en) | 2004-10-07 | 2007-05-17 | Duramed Pharmaceuticals, Inc. | Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens |
JP2016516732A (ja) | 2013-03-18 | 2016-06-09 | エボニック レーム ゲゼルシャフト ミット ベシュレンクテル ハフツングEvonik Roehm GmbH | メタクリル酸及びメタクリル酸エステルの製造方法 |
EP3608305A1 (de) | 2018-08-10 | 2020-02-12 | Röhm GmbH | Verfahren zur herstellung von methacrylsäure oder methacrylsäureestern |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4210637A (en) * | 1978-07-31 | 1980-07-01 | Massachusetts Institute Of Technology | Composition and method for suppressing appetite for calories as carbohydrates |
US4309445A (en) * | 1980-06-16 | 1982-01-05 | Massachusetts Institute Of Technology | d-Fenfluramine for modifying feeding behavior |
GB2129299A (en) | 1982-11-09 | 1984-05-16 | Alec James Coppen | Pharmaceutical compositions |
US4590213A (en) * | 1983-04-08 | 1986-05-20 | Eli Lilly And Company | Anti-anxiety method |
US4649161A (en) | 1986-06-16 | 1987-03-10 | Massachusetts Institute Of Technology | Method for treating depression with d-fenfluramine |
-
1988
- 1988-10-21 DE DE3856295T patent/DE3856295T2/de not_active Expired - Fee Related
- 1988-10-21 JP JP63509530A patent/JP2938463B2/ja not_active Expired - Fee Related
- 1988-10-21 AT AT88910336T patent/ATE175358T1/de not_active IP Right Cessation
- 1988-10-21 EP EP88910336A patent/EP0386117B1/de not_active Expired - Lifetime
- 1988-10-21 WO PCT/US1988/003709 patent/WO1989003692A1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
JP2938463B2 (ja) | 1999-08-23 |
DE3856295T2 (de) | 1999-06-17 |
DE3856295D1 (de) | 1999-02-18 |
EP0386117B1 (de) | 1999-01-07 |
JPH03500884A (ja) | 1991-02-28 |
EP0386117A1 (de) | 1990-09-12 |
WO1989003692A1 (en) | 1989-05-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE175358T1 (de) | Behandlung des prämenstruellen oder späten lutealsphase-syndroms | |
ATE128864T1 (de) | Zusammensetzung zur behandlung der symptome verursacht durch beseitigung von tabak. | |
DE3483040D1 (de) | Maschinelesbares dokument und dessen behandlung. | |
NO900837D0 (no) | Hylster til roekeartikler og fremgangsmaate til dets behandling. | |
DE69202207D1 (de) | Verfahren zur Herstellung von 1-Chlor-1,1,3,3,3-Pentafluorpropan und von 1,1,1,3,3,3-Hexafluorpropan. | |
DE3779346D1 (de) | Zusammensetzung zur behandlung der haut. | |
DE3870508D1 (de) | Zusammensetzung zur behandlung des haares. | |
NO873699L (no) | Polypeptid som er egnet til dempning, behandling og diagnostisering av autoimmune lidelser saasom leddbetennelser. | |
IT8021233A0 (it) | Procedimento per deodorare e/o disacidare composti organici altobollenti, in particolare olii alimentari. | |
NO964238L (no) | Halofantrin-fri-base for behandling av malaria og blandinger | |
DE69110713D1 (de) | 7-Oxabicycloheptan-imidazol-prostaglandin-Analoge, verwendbar bei der Behandlung von thrombotischen und vasospastischen Erkrankungen. | |
NO900358D0 (no) | Fremgangsmaate og innretning for behandling av faststoff-gass-blandinger som skal pumpes. | |
PT66089A (en) | Process for preparing 1,2-benzisothiazolin-3-ona with anti-thrombotic effect,application of same for the preparation of pharmaceutical compositions with anti-thrombic effect and application of these pharmaceutical compositions for the treatment of thrombosis | |
IT7926382A0 (it) | Trattamento del gas di spurgo nella sintesi della ammoniaca. | |
ES483661A1 (es) | Procedimiento para la obtencion de derivados de 1,4-dihidro-piridina sila-sustituidos | |
NL7607335A (nl) | Werkwijze voor de bereiding van 4,4,6-trime- thyl-2-cyclohexenon alsmede de toepassing daarvan in reukmiddelmengsels. | |
CA2002182A1 (en) | Compositions for treating the premenstrual or late luteal phase syndrome and methods for their use | |
NL7612682A (nl) | Werkwijze en inrichting voor de warmtebehande- ling van waren, alsmede waren behandeld onder toepassing van de werkwijze. | |
ES2089286T3 (es) | Nuevas 2-amino-5-ciano-1,4-dihidropiridinas, procedimiento para su preparacion y su uso en medicamentos. | |
DE3676640D1 (de) | Prazosin-pirbuterol-mischung zur bronchendilatation. | |
IT8420682A0 (it) | Procedimento per il trattamento di articoli di maglieria. | |
ATE130304T1 (de) | Neue alpha-glukosidaseinhibitoren. | |
ATE122886T1 (de) | Verwendung von 1,4-dihydropyridin-derivaten in der behandlung von alkoholsucht. | |
ES2061775T3 (es) | Derivados de estrobirulina, su obtencion y empleo. | |
IT8421046A0 (it) | Composizione farmaceutica per il trattamento dell'aritmia e relativo processo antiaritmico. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |